Simulation to Improve Infection Prevention and Patient Safety: The SIPPS Trial

通过模拟改善感染预防和患者安全:SIPPS 试验

基本信息

项目摘要

Standard precautions (SP) are a fundamental set of actions, including hand hygiene and use of personal protective equipment and sharps safety devices, that every healthcare provider should perform in every contact with every patient to prevent patient healthcare associated infections (HAIs) and occupational blood-borne pathogen exposures. Despite well established, longstanding guidelines and usual training, SP are not reliably practiced, with self-reported adherence among nurses (who have the largest proportion of direct patient contact in acute care) less than 50%. HAIs are a substantial public health problem affecting approximately 2 million patients annually, resulting in 99,000 estimated deaths and occupational blood-borne pathogen exposures to 1 in 25 registered nurses. One promising mechanism that may improve SP adherence is simulation training, an emerging and effective educational approach to enhance healthcare workers' performance. This study will test a simulation intervention designed to improve provider performance of SP and prevent HAIs and occupational blood-borne pathogen exposures. The aims of this project, “Simulation to Improve Infection Prevention and Patient Safety: The SIPPS Trial,” are to: 1) determine the effect of simulation training on nurse knowledge, observed SP adherence, and HAI and nurse blood-borne pathogen exposure rates; 2) determine whether patient safety culture modifies the effect of training on observed SP adherence and knowledge; and 3) determine maximal duration (sustainability) of the simulation intervention on clinical performance of SP adherence. Our research objectives, methodology, specification of measures, and simulation implementation plan are innovatively guided by both a conceptual framework (Human Factors Framework) and implementation model (Consolidated Framework for Implementation Research). We will conduct a 5-year group-randomized, group-interventional trial to test a clinical in-situ (i.e., taking place in a live, operational, clinical setting) simulation training intervention and include approximately 336 direct care registered nurses from a total of 12 units from two hospitals in two states. Unique survey, direct observation, focus group, and secondary data will be collected and aggregated to answer our research questions. This project will be supported by the expertise and resources from world-class academic and clinical settings committed to advancing patient safety through simulation research. Results will be disseminated in an in-situ toolkit to include a SP curriculum and video training. Hospitalized patients, including women and minorities, the elderly, inner city residents, and the chronically ill - AHRQ priority populations - serve to benefit from improved adherence to standard precautions, and health care workers will benefit from enhanced “real world” training and support to reduce their exposure to blood-borne pathogens. Ultimately, knowledge gained from this prioritized research will inform key stakeholders of the vital role that simulation training performs in patient safety and in advancing national aims for healthcare improvement.
标准预防措施(SP)是一套基本的行动,包括手卫生和使用

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amanda Jane Hessels其他文献

Amanda Jane Hessels的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amanda Jane Hessels', 18)}}的其他基金

Simulation to Improve Infection Prevention and Patient Safety: The SIPPS Trial
通过模拟改善感染预防和患者安全:SIPPS 试验
  • 批准号:
    10569500
  • 财政年份:
    2019
  • 资助金额:
    $ 36.19万
  • 项目类别:
Impact of Patient Safety Climate on Infection Prevention Practices and Healthcare Worker and Patient Outcomes
患者安全氛围对感染预防实践以及医护人员和患者结果的影响
  • 批准号:
    9339338
  • 财政年份:
    2016
  • 资助金额:
    $ 36.19万
  • 项目类别:
Impact of Heath Information Technology on Delivery and Quality of Patient Care
健康信息技术对患者护理服务和质量的影响
  • 批准号:
    8465002
  • 财政年份:
    2012
  • 资助金额:
    $ 36.19万
  • 项目类别:

相似海外基金

Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program to Improve the Functioning of Persons Suffering from Post-acute Sequelae of SARS-CoV-2 infection (PASC): A Randomized Controlled
评估综合多模式门诊康复计划以改善 SARS-CoV-2 感染急性后遗症患者的功能 (PASC):一项随机对照研究
  • 批准号:
    10583969
  • 财政年份:
    2023
  • 资助金额:
    $ 36.19万
  • 项目类别:
Slippery Omniphobic Coating for Hemodialysis Catheter to Resist Fibrin Sheathing and Infection and Improve Patient Outcomes
用于血液透析导管的光滑全疏涂层可抵抗纤维蛋白鞘和感染并改善患者预后
  • 批准号:
    10759575
  • 财政年份:
    2023
  • 资助金额:
    $ 36.19万
  • 项目类别:
Enhanced Antifungal Therapy to Improve Survival in Early Disseminated Cryptococcal Infection
加强抗真菌治疗可提高早期播散性隐球菌感染的生存率
  • 批准号:
    10621009
  • 财政年份:
    2023
  • 资助金额:
    $ 36.19万
  • 项目类别:
Integrated Host/Microbe Metagenomics to Improve Lower Respiratory Tract Infection Diagnosis in Critically Ill Children
整合宿主/微生物宏基因组学以改善危重儿童下呼吸道感染诊断
  • 批准号:
    10333318
  • 财政年份:
    2021
  • 资助金额:
    $ 36.19万
  • 项目类别:
Can Senolytics Improve the Aged Response to Viral Infection
Senolytics 能否改善老年人对病毒感染的反应
  • 批准号:
    10475231
  • 财政年份:
    2021
  • 资助金额:
    $ 36.19万
  • 项目类别:
Can Senolytics Improve the Aged Response to Viral Infection
Senolytics 能否改善老年人对病毒感染的反应
  • 批准号:
    10303445
  • 财政年份:
    2021
  • 资助金额:
    $ 36.19万
  • 项目类别:
Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection
通过靶向病毒感染后的簇细胞改善肺再生
  • 批准号:
    10679030
  • 财政年份:
    2021
  • 资助金额:
    $ 36.19万
  • 项目类别:
Interventions to improve alcohol-related comorbidities along the gut-brain axis in persons with HIV infection
改善 HIV 感染者沿肠-脑轴的酒精相关合并症的干预措施
  • 批准号:
    10682449
  • 财政年份:
    2021
  • 资助金额:
    $ 36.19万
  • 项目类别:
Administrative Core: Interventions to improve alcohol-related comorbidities along the gut-brain axis in persons with HIV infection
行政核心:改善艾滋病毒感染者沿肠-脑轴的酒精相关合并症的干预措施
  • 批准号:
    10682451
  • 财政年份:
    2021
  • 资助金额:
    $ 36.19万
  • 项目类别:
Data Science Core: Interventions to improve alcohol-related comorbidities along the gut-brain axis in persons with HIV infection
数据科学核心:改善 HIV 感染者肠脑轴酒精相关合并症的干预措施
  • 批准号:
    10682453
  • 财政年份:
    2021
  • 资助金额:
    $ 36.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了